Balchem Corporation to Participate in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026
Rhea-AI Summary
Balchem (NASDAQ: BCPC) will participate in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026. Company executives Ted Harris (Chairman, President & CEO), Martin Bengtsson (CFO) and Allison Baurichter (Senior Director Investor Relations) will attend and speak.
Positive
- None.
Negative
- None.
News Market Reaction – BCPC
In the Feb 25 session, BCPC gained 0.59%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 20 | Earnings release | Positive | -3.6% | Record 2025 sales, earnings and free cash flow with higher dividend. |
| Feb 06 | Earnings call notice | Neutral | -0.3% | Scheduled Q4 and full-year 2025 results conference call details. |
| Jan 02 | Investor conference | Neutral | +0.4% | Participation in CJS virtual conference to discuss strategy with investors. |
| Dec 22 | Regulatory trade action | Positive | +0.5% | EU anti-dumping duties on Chinese choline chloride imports for five years. |
| Dec 10 | Dividend increase | Positive | +2.4% | Annual dividend of $0.96 per share, up 10.3%, seventeenth straight increase. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
BCPC’s news flow has generally seen price moves align with positive developments, except for a recent strong earnings report that coincided with a short-term decline.
This announcement adds another investor-focused event to a steady stream of recent corporate updates. On Feb 20, 2026, Balchem reported record $1.037 billion 2025 net sales and record adjusted EBITDA of $274.9 million, yet shares fell 3.6%. Prior items included the Feb 20 earnings call notice, January and February conference appearances, supportive EU anti-dumping duties on choline chloride published Dec 19, 2025, and a $0.96 dividend with a 10.3% increase, which drew a positive market reaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MONTVALE, N.J., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference.
About Balchem Corporation
Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.
Contact: Jacqueline Yarmolowicz
Balchem Corporation (Telephone: 845-326-5600)
